Andrey Dorofeev - Strategy Director
Professional Overview
Andrey Dorofeev is an accomplished business strategy professional with over 12 years of experience driving growth and optimization initiatives across the pharmaceutical and consumer goods industries. As the Strategy Director at ACINO, he leverages his expertise in strategic planning, market analysis, and organizational transformation to guide the company's long-term vision and operational excellence.
Experience Summary
Current Role
As the Strategy Director at ACINO since February 2020, Andrey is responsible for leading the organization's strategic planning and execution processes. He collaborates closely with the executive team to develop and implement comprehensive growth strategies, identify new market opportunities, and optimize operational efficiency. Under his guidance, ACINO has successfully expanded its product portfolio, enhanced its customer engagement, and achieved significant improvements in profitability.
Career Progression
Prior to joining ACINO, Andrey held various strategy and business development roles at leading pharmaceutical companies, including Sanofi, Abbott, and the Biopharma Business of Merck. As the Head of Base Business at Sanofi, he spearheaded strategic initiatives that increased the company's market share and streamlined operational processes, resulting in a 15% improvement in profitability. In his previous roles at Abbott and Merck, Andrey demonstrated his expertise in market analysis, new product development, and strategic partnerships, contributing to the successful launch of several innovative products.
Academic Background
Andrey holds a Master's degree in Business Administration from the Moscow State University, where he graduated with honors. His academic focus on strategic management, international business, and organizational behavior has provided a strong foundation for his professional success.
Areas of Expertise
- Strategic planning and execution
- Market analysis and competitive intelligence
- New product development and portfolio optimization
- Organizational transformation and change management
- Cross-functional team leadership and collaboration
Professional Impact
Throughout his career, Andrey has been recognized for his ability to drive measurable business results. At Sanofi, he led a strategic initiative that increased the company's market share by 12% in a highly competitive therapeutic area. At Abbott, he spearheaded the successful launch of a new pharmaceutical product that generated $25 million in revenue within the first year. Andrey's industry contributions and leadership have earned him a reputation as a trusted advisor and strategic partner.
Conclusion
With his deep industry knowledge, analytical acumen, and strategic leadership, Andrey Dorofeev is poised to continue his successful trajectory as the Strategy Director at ACINO. He is committed to leveraging his expertise to help the organization achieve its ambitious growth objectives and solidify its position as a leading player in the pharmaceutical industry.
